160 related articles for article (PubMed ID: 32407159)
21. Comparisons of choroidal blood flow velocity between initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy.
Abu El-Asrar AM; AlBloushi AF; Abouammoh MA; Alzubaidi A; Gikandi PW; Al Faran A; Al-Kharashi AS; Al-Dahmash S
Eye (Lond); 2024 May; 38(7):1269-1275. PubMed ID: 38129662
[TBL] [Abstract][Full Text] [Related]
22. Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study.
Abrishami M; Emamverdian Z; Shoeibi N; Omidtabrizi A; Daneshvar R; Saeidi Rezvani T; Saeedian N; Eslami S; Mazloumi M; Sadda S; Sarraf D
Can J Ophthalmol; 2021 Feb; 56(1):24-30. PubMed ID: 33249111
[TBL] [Abstract][Full Text] [Related]
23. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
24. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.
Takemoto Y; Namba K; Mizuuchi K; Iwata D; Uno T; Ohno S; Hirooka K; Hashimoto Y; Saito W; Sugiyama K; Ishida S
Acta Ophthalmol; 2016 Nov; 94(7):e629-e636. PubMed ID: 27079805
[TBL] [Abstract][Full Text] [Related]
25. Ocular Inflammation and Choroidal Thickness after Pars Plana Vitrectomy in Chronic Recurrent Stage of Vogt-Koyanagi-Harada Disease.
Park UC; Yu HG
Ocul Immunol Inflamm; 2021 Feb; 29(2):388-395. PubMed ID: 31671005
[No Abstract] [Full Text] [Related]
26. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
27. Visual function in Vogt-Koyanagi-Harada patients.
Chee SP; Luu CD; Cheng CL; Lim WK; Jap A
Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):785-90. PubMed ID: 15761760
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in
Hagag AM; Mitsios A; Gill JS; Nunez Do Rio JM; Theofylaktopoulos V; Houston S; Webster AR; Dubis AM; Moosajee M
Br J Ophthalmol; 2020 Apr; 104(4):480-486. PubMed ID: 31266775
[TBL] [Abstract][Full Text] [Related]
29. Normative database and determinants of macular vessel density measured by optical coherence tomography angiography.
Fernández-Vigo JI; Kudsieh B; Shi H; Arriola-Villalobos P; Donate-López J; García-Feijóo J; Ruiz-Moreno JM; Fernández-Vigo JÁ
Clin Exp Ophthalmol; 2020 Jan; 48(1):44-52. PubMed ID: 31574573
[TBL] [Abstract][Full Text] [Related]
30. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of capillary plexus with visual acuity in idiopathic macular epiretinal membrane eyes using optical coherence tomography angiography].
Mao JB; Lao JM; Yu XT; Chen YQ; Tao JW; Wu HF; Cheng D; Chen H; Shen LJ
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):757-762. PubMed ID: 31607064
[No Abstract] [Full Text] [Related]
32. SS OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease.
Ben Aoun S; Ksiaa I; Nefzi D; Khochtali S; Jelliti B; Abroug N; Khairallah M
Ocul Immunol Inflamm; 2024 May; 32(4):407-414. PubMed ID: 37948509
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the direct effects on retinal and choroidal microvascularity of systemic scleroderma.
Kök M; Ayan A; Fatih Küçük M; Erol MK; Yaprak L
Microvasc Res; 2021 Jul; 136():104166. PubMed ID: 33845106
[TBL] [Abstract][Full Text] [Related]
34. Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation.
Nazari H; Hariri A; Hu Z; Ouyang Y; Sadda S; Rao NA
J Ophthalmic Inflamm Infect; 2014; 4():9. PubMed ID: 24655594
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Ocular Hypoperfusion in Patients with Acromegaly by Using Optical Coherence Tomography Angiography.
Karahan M; Demirtaş AA; Erdem S; Ava S; Pekkolay Z; Keklikçi U
Curr Eye Res; 2021 Aug; 46(8):1209-1213. PubMed ID: 33445974
[TBL] [Abstract][Full Text] [Related]
36. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
[TBL] [Abstract][Full Text] [Related]
37. Microvasculature Features of Vogt-Koyanagi-Harada Disease Revealed by Widefield Swept-Source Optical Coherence Tomography Angiography.
Ye X; Zhang H; Xiao P; Wang G; Hu X; Yan C; Li F; Hu Y; Su L; Luo J; Yuan J; Wen F; Chi W
Front Med (Lausanne); 2021; 8():719593. PubMed ID: 34722564
[No Abstract] [Full Text] [Related]
38. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the effect of smokeless tobacco (Maras powder) on choroidal and retinal blood flow: an optical coherence tomography angiography study.
Çömez A; Karaküçük Y; Beyoğlu A
Int Ophthalmol; 2020 Jun; 40(6):1367-1376. PubMed ID: 32383132
[TBL] [Abstract][Full Text] [Related]
40. Optical Coherence Tomography-Based Quantification of Photoreceptor Injury and Recovery in Vogt-Koyanagi-Harada Uveitis.
Bae SS; Forooghian F
Ocul Immunol Inflamm; 2017 Jun; 25(3):338-343. PubMed ID: 26903383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
